Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) may have multiple therapeutic applications for cell based therapy including the treatment of pulmonary artery hypertension (PAH). As low survival rates and potential tumorigenicity of implanted cells could undermine the mesenchymal stem cell (MSC) cell-based therapy, we chose to investigate the use of conditioned medium (CM) from a culture of MSC cells as a feasible alternative. Methods: CM was prepared by culturing hUCB-MSCs in three-dimensional spheroids. In a rat model of PAH induced by monocrotaline, we infused CM or the control unconditioned culture media via the tail-vein of 6-week-old Sprague-Dawley rats. Results: Compared with the control unconditioned media, CM infusion reduced the ventricular pressure, the right ventricle/(left ventricle+interventricular septum) ratio, and maintained respiratory function in the treated animals. Also, the number of interleukin 1α (IL-1α), chemokine (C-C motif) ligand 5 (CCL5), and tissue inhibitor of metalloproteinase 1 (TIMP-1)–positive cells increased in lung samples and the number of terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling technique (TUNEL)–positive cells decreased significantly in the CM treated animals. Conclusions: From our in vivo data in the rat model, the observed decreases in the TUNEL staining suggest a potential therapeutic benefit of the CM in ameliorating PAH-mediated lung tissue damage. Increased IL-1α, CCL5, and TIMP-1 levels may play important roles in this regard.
Abstract
Background: Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) may have multiple therapeutic applications for cell based therapy including the treatment of pulmonary artery hypertension (PAH). As low survival rates and potential tumorigenicity of implanted cells could undermine the mesenchymal stem cell (MSC) cell-based therapy, we chose to investigate the use of conditioned medium (CM) from a culture of MSC cells as a feasible alternative. Methods: CM was prepared by culturing hUCB-MSCs in three-dimensional spheroids. In a rat model of PAH induced by monocrotaline, we infused CM or the control unconditioned culture media via the tail-vein of 6-week-old Sprague-Dawley rats. Results: Compared with the control unconditioned media, CM infusion reduced the ventricular pressure, the right ventricle/(left ventricle+interventricular septum) ratio, and maintained respiratory function in the treated animals. Also, the number of interleukin 1α (IL-1α), chemokine (C-C motif) ligand 5 (CCL5), and tissue inhibitor of metalloproteinase 1 (TIMP-1)–positive cells increased in lung samples and the number of terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling technique (TUNEL)–positive cells decreased significantly in the CM treated animals. Conclusions: From our in vivo data in the rat model, the observed decreases in the TUNEL staining suggest a potential therapeutic benefit of the CM in ameliorating PAH-mediated lung tissue damage. Increased IL-1α, CCL5, and TIMP-1 levels may play important roles in this regard.
참고문헌 (43)
- Farber HW, "Pulmonary arterial hypertension", N Engl J Med, 351, pp.1655~1665 (2004)
- Liang OD, "Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension", Stem Cells, 29, pp.99~107 (2011)
- Can MM, "Enhanced hemostatic indices in patients with pulmonary arterial hypertension : an observational study", Thromb Res, 126, pp.280~282 (2010)
- Fukumoto Y, "Recent progress in the management of pulmonary hypertension", Circ J, 75, pp.1801~1810 (2011)
- Liu Q, "Conditioned serum-free medium from umbilical cord mesenchymal stem cells has anti-photoaging properties", Biotechnol Lett, 35, pp.1707~1714 (2013)
- 이재철, "Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats", Anatomy and Cell Biology, 47(4), pp.217~226 (2014), 대한해부학회
- Zhao YD, "Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer", Am J Respir Cell Mol Biol, 35, pp.182~189 (2006)
- Saigawa T, "Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells", Circ J, 68, pp.1189~1193 (2004)
- Kang H, "The therapeutic effects of human mesenchymal stem cells primed with sphingosine-1 phosphate on pulmonary artery hypertension", Stem Cells Dev, 24, pp.1658~1671 (2015)
- Umar S, "Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension", Am J Physiol Heart Circ Physiol, 297, pp.H1606~H1616 (2009)
- Kim AK, "Stem-cell therapy for peripheral arterial occlusive disease", Eur J Vasc Endovasc Surg, 42, pp.667~675 (2011)
- Lee KB, "Stem cell therapy in patients with thromboangiitis obliterans : assessment of the long-term clinical outcome and analysis of the prognostic factors", Int J Stem Cells, 4, pp.88~98 (2011)
- Yang SS, "A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease", Int J Stem Cells, 6, pp.37~44 (2013)
- Cho YJ, "Therapeutic effects of human adipose stem cell-conditioned medium on stroke", J Neurosci Res, 90, pp.1794~1802 (2012)
- Lim HC, "Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington’s disease", Neurosci Lett, 435, pp.175~180 (2008)
- Lee EJ, "Spherical bullet formation via Ecadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction", Mol Ther, 20, pp.1424~1433 (2012)
- Pereira T, "MSCs conditioned media and umbilical cord blood plasma metabolomics and composition", PLoS One, 9, pp.e113769~ (2014)
- Lipke DW, "Temporal alterations in specific basement membrane components in lungs from monocrotaline-treated rats", Am J Respir Cell Mol Biol, 9, pp.418~428 (1993)
- Bieback K, "Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood", Stem Cells, 22, pp.625~634 (2004)
- Wang M, "The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro", Immunology, 126, pp.220~232 (2009)
- Jeong SY, "Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation", Stem Cells, 31, pp.2136~2148 (2013)
- Kim JY, "Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-beta plaques", Cell Death Differ, 19, pp.680~691 (2012)
- Jin H, "Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt", Cell Transplant, 22, pp.1637~1650 (2013)
- Yang S, "Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells", J Neurosci Res, 91, pp.978~986 (2013)
- Yang C, "Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro", Biomed Res Int, 2014, pp.109389~ (2014)
- Jiang Y, "Pluripotency of mesenchymal stem cells derived from adult marrow", Nature, 418, pp.41~49 (2002)
- Mareschi K, "Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow", J Cell Biochem, 97, pp.744~754 (2006)
- Secco M, "Multipotent stem cells from umbilical cord: cord is richer than blood!", Stem Cells, 26, pp.146~150 (2008)
- Kim ES, "Conditioned media from human umbilical cord blood-derived mesenchymal stem cells inhibits melanogenesis by promoting proteasomal degradation of MITF", PLoS One, 10, pp.e0128078~ (2015)
- Kim JY, "Galectin-3 secreted by human umbilical cord blood-derived mesenchymal stem cells reduces amyloid-beta42 neurotoxicity in vitro", FEBS Lett, 584, pp.3601~3608 (2010)
- Flynn A, "UC blood-derived mesenchymal stromal cells: an overview", Cytotherapy, 9, pp.717~726 (2007)
- Dranoff G, "Cytokines in cancer pathogenesis and cancer therapy", Nat Rev Cancer, 4, pp.11~22 (2004)
- Chandrasekar B, "The ELR+ CXC chemokine LIX(CXCL5)amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway", J Biol Chem, 278, pp.4675~4686 (2003)
- Brew K, "Tissue inhibitors of metalloproteinases:evolution, structure and function", Biochim Biophys Acta, 1477, pp.267~283 (2000)
- Bourboulia D, "Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion", Semin Cancer Biol, 20, pp.161~168 (2010)
- Jiang Y, "Complex roles of tissue inhibitors of metalloproteinases in cancer", Oncogene, 21, pp.2245~2252 (2002)
- Stetler-Stevenson WG, "Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities", Sci Signal, 1, pp.re6~ (2008)
- Furie MB, "Chemokines and tissue injury", Am J Pathol, 146, pp.1287~1301 (1995)
- Kaneider NC, "Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions", FEBS J, 273, pp.4416~4424 (2006)
- Kolb M, "Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis", J Clin Invest, 107, pp.1529~1536 (2001)
- Johnston CJ, "Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation", Radiat Res, 145, pp.762~767 (1996)
- Phan SH, "Lung cytokine production in bleomycin-induced pulmonary fibrosis", Exp Lung Res, 18, pp.29~43 (1992)
- Pan LH, "Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases : an immunohistochemical analysis", Pathol Int, 46, pp.91~99 (1996)